PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments

21 1 2025 08:00:01 提供 Nasdaq GlobeNewswire

Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization

10 1 2025 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Receives FDA 510k Clearance for New iovera° SmartTip to Manage Chronic Low Back Pain via Long-lasting Medial Branch Nerve Block

07 1 2025 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

02 1 2025 16:01:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

06 12 2024 08:00:00 提供 Nasdaq GlobeNewswire

Pacira Awarded New U.S. Patent Covering EXPAREL Composition

03 12 2024 07:30:00 提供 Nasdaq GlobeNewswire

Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

14 11 2024 10:05:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences

12 11 2024 08:00:01 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Third Quarter 2024 Financial Results

06 11 2024 16:00:00 提供 Nasdaq GlobeNewswire

Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings

04 11 2024 08:00:00 提供 Nasdaq GlobeNewswire

Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024

30 10 2024 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer

21 10 2024 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

07 10 2024 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025

03 10 2024 08:00:43 提供 Nasdaq GlobeNewswire

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

26 9 2024 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

09 9 2024 16:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

13 8 2024 09:46:30 提供 NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

12 8 2024 09:45:52 提供 NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

09 8 2024 15:55:27 提供 NetDania Notify

Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey

09 8 2024 15:21:31 提供 Nasdaq GlobeNewswire